Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:FA_Cup
|
| gptkbp:administered_by |
gptkb:oil
gptkb:food vapor tinctures |
| gptkbp:advocacy |
gptkb:Marijuana_Policy_Project
gptkb:Drug_Policy_Alliance gptkb:NORML |
| gptkbp:associated_with |
gptkb:traditional_medicine
holistic health |
| gptkbp:available_in |
various forms
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:contains |
gptkb:CBD
gptkb:THC cannabinoids |
| gptkbp:controversy |
legalization debates
medical efficacy debates |
| gptkbp:cultural_significance |
in some societies
|
| gptkbp:economic_impact |
job creation
tax revenue generation cannabis industry growth |
| gptkbp:healthcare |
home delivery services
telemedicine consultations dispensaries compassionate use programs |
| gptkbp:historical_use |
gptkb:traditional_medicine
ancient medicine |
| https://www.w3.org/2000/01/rdf-schema#label |
medical cannabis
|
| gptkbp:is_regulated_by |
government agencies
|
| gptkbp:legal_status |
varies by country
|
| gptkbp:notable_users |
patients with chronic illnesses
patients undergoing chemotherapy patients with PTSD |
| gptkbp:public_perception |
stigma reduction
increasing acceptance |
| gptkbp:requires |
in some jurisdictions
|
| gptkbp:research |
cannabinoid receptors
therapeutic potential safety profiles endocannabinoid system |
| gptkbp:research_focus |
gptkb:cancer_treatment
gptkb:epilepsy gptkb:multiple_sclerosis chronic pain |
| gptkbp:side_effect |
anxiety
dizziness fatigue dry mouth |
| gptkbp:trends |
development of new products
more research funding increased legalization integration into healthcare systems |
| gptkbp:used_for |
nausea
pain relief appetite stimulation |
| gptkbp:bfsParent |
gptkb:Snoop_Dogg
|
| gptkbp:bfsLayer |
4
|